Adimab, Llc Adagio Therapeutics, Inc. (ADGI) insider trading activity

ADGI Quotes by TradingView

Adimab, LLC is of Adagio Therapeutics, Inc.. Currently has a direct ownership of 21.7 Million shares of ADGI, which is worth approximately $71.8 Million. The most recent transaction as insider was on Jan 19, 2024, when has been sold 5,000,000 shares (Common Stock) at a price of $3.95 per share, resulting in proceeds of $19,750,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.7M
0% 3M change
18.74% 12M change
Total Value Held $71.8 Million

Adimab, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2024
SELL
Open market or private sale
$19,750,000 $3.95 p/Share
5,000,000 Reduced 18.74%
21,687,906 Common Stock
Mar 03 2022
SELL
Other acquisition or disposition
-
1,158,089 Reduced 4.16%
26,687,906 Common Stock
Aug 10 2021
BUY
Conversion of derivative security
-
25,860,700 Added 48.15%
27,845,995 Common Stock
AL

Adimab, LLC

Lebanon, NH

Track Institutional and Insider Activities on ADGI

Follow Adagio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADGI shares.

Notify only if

Insider Trading

Get notified when an Adagio Therapeutics, Inc. insider buys or sells ADGI shares.

Notify only if

News

Receive news related to Adagio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADGI